glp-1 drugs impact on energy levels Does Make You Tired? Understanding Fatigue and Solutions Do GLP-1 Medications Make You
Description
Initially developed for treating type 2 diabetes, their remarkable impact on weight loss soon became apparent

For all-cause mortality and RFS in patients with obesity, the 5-year survival probability was 97.4% and 96% with GLP-1 RA use, and 93.2% and 91.3% with non-use, respectively

Clinical trial data using body-composition analysis show that fat mass accounts for the majority of weight loss, while lean-mass changes reflect normal physiologic adaptation to reduced body weight and energy intake. Understanding this distinction is criticalbecause muscle wasting and expected lean-mass adaptation are not the same thing
18 Longer-acting GLP-1 RAs are associated with less robust effects on postprandial glucose and greater effects on fasting glucose
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
Here, we summarize data supporting the use of GLP-1RAs for the treatment of neurodegenerative diseases, with a focus on AD

Nutrients (2019) 11:1664
